Home » Whole-Genome Sequencing Could Complement GWAS to Find Rare Variants Associated with Disease Risk

Whole-Genome Sequencing Could Complement GWAS to Find Rare Variants Associated with Disease Risk

Mar 08, 2011
Premium

By Monica Heger

Whole-genome sequencing in combination with genome-wide association studies could be the key to uncovering rare variants associated with disease risk, according to researchers from Decode Genetics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Related Articles

May 09, 2014

NextCode Seeks to Build Business on Proprietary Informatics Infrastructure from DeCode

Premium
Jul 21, 2014

Sequencing Uncovers Rare Variants Linked to Noonan Syndrome, Aids in Diagnosis

Jan 19, 2015

Young Investigator Profile: Gina Peloso

Jun 19, 2014

Genomics in the Journals

Apr 03, 2014

Rare Variants Linked to Congenital Heart Defects in Humans

Apr 29, 2014

Exome Sequencing Study Identifies Chromatin Remodeling-related Mutations in Schizophrenia

The Scan

Ancient Wheat

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

'High School Never Ends'

Joel Achenbach explores at National Geographic why people find science difficult to believe.

This Week in Science

In Science this week: gene linked to expansion of the human neocortex, and more.

Bit of an Increase

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

What's Popular?

In Clinical Sequencing

  1. AGBT: WashU Applies Genomic Testing to Predict Cancer Relapse, Drug Response, Vaccine Epitopes

    Premium

  2. At Prenatal Molecular Dx Conference, NIPT Providers Offer Glimpse into Strategies

    Premium

  3. Mayo Clinic Commercial Spinout Oneome Hoping to Advance PGx Analysis of Patient NGS Data

    Premium

  4. Personal Genome Diagnostics Aims for FDA Clearance of NGS-based Cancer Products

    Premium

  5. Qiagen Acquires Enzymatics, Inks Partnership with ArcherDX

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.